Brain Development: Neural Signature Predicts Autism's Emergence A new study has found that neural sensitivity to eye gaze in early infancy is associated with subsequent development of autism. This discovery provides a much-needed biomarker for autism spectrum disorder prior to emergence of behavioral symptoms.
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Autism spectrum disorder (ASD) is a common, early-onset neurodevelopmental disorder characterized by difficulties in social interaction and communication and repetitive or restricted interests and behaviors [1] . ASD displays great phenotypic heterogeneity and etiological diversity, but since its original description, social dysfunction has been its hallmark and unifying feature [2] . This social dysfunction is revealed by abnormalities in both simple behaviors, such as sharing gaze, and more complex social behaviors, such as triadic attention sharing. Anomalies of social perception, unlike communication problems or repetitive behaviors that are present in numerous disorders (such as anxiety or expressive language impairment), are unique to ASD and are documented across sensory modalities. Autism is a developmental disorder; early deficits derail subsequent experiences, thereby canalizing development towards more severe dysfunction and creating sequelae in additional domains of function. Consequently, the lack of reliable predictors of the condition during the first year of life has been a major impediment to the effective treatment of ASD. Without early predictors and in the absence of a firm diagnosis until behavioral symptoms emerge, treatment is often delayed for two or more years.
In response to the urgent need for a sensitive and specific biomarker of ASD, many research groups from around the world have been intensely studying patterns of infant development. These studies have involved prospective longitudinal studies of infant siblings of children with ASD. Such designs use a comparison group of infant siblings without familial risks (the low-risk group) to gather longitudinal information about developmental trajectories across the first three years of life, followed by clinical diagnosis at 36 months. As recently reviewed by Rogers [3] , the behavioral work to date, using measures such as eye-tracking and social probes, has failed to detect atypical social development in the first months of life, instead portraying ''autism as a disorder involving symptoms across multiple domains with a gradual onset that changes both ongoing developmental rate and established behavioral patterns across the first 2-3 years of life''.
The findings presented in this issue of Current Biology by Elsabbagh and colleagues [4] challenge this notion and remind us that our ability to study development is contingent upon the power of our methods of inquiry. Their provocative results suggest that investigation at the neural systems level may reveal distinctions inaccessible to behavioral assays alone. They tested the hypothesis that neural sensitivity to eye gaze in early infancy would predict development of ASD in toddlerhood. The study involved a prospective longitudinal sample of infants at high familial risk for ASD and a comparison group of infants at low risk. The researchers recorded electrophysiological brain responses (event-related potentials; ERPs) while 6-10 month-old infants viewed faces with dynamic eye gaze directed either towards them or away from them. Approximately 18 to 30 months later, these children were clinically evaluated for the presence of an ASD. Strikingly, neural responses to dynamic eye gaze shifts during the first year predicted clinical outcomes at 36 months, despite similar patterns of gaze as measured by eye tracking. The authors [4] conclude that ERP responses to eye gaze in the first year of life reflect developmental processes leading to the later emergence of ASD.
As the field strives for earlier methods of detecting autistic development, these remarkable findings offer hope for future clinical practice, suggesting the possibility of non-invasive, brain-based screening methods that could detect differences prior to behavioral emergence. ERPs are collected with the same technology (electroencephalography) commonly used in hospitals around the world for universal auditory screening of newborns; the infrastructure might already be in place to implement population-based screening in an affordable and highly efficient manner [5] . Of course, prior to realization of such clinical benefits, it will be critical to investigate the specificity of this biomarker to autism, its presence in an unselected, population-based sample, and, most importantly, its viability in individual patient data. Given historical difficulty parsing heterogeneity in ASD, these findings suggest the potential power of systems neuroscience approaches to identify meaningful subtypes of ASD to inform treatment and predicting outcome. We envision a strategy of deep behavior and brain phenotyping over longitudinal development to offer a detailed profile of brain-behavior performance for a given individual for the purpose of detection of atypical development, subcategorization (for example, for genetic analysis), treatment selection, and prediction of treatment response.
There is an important historical perspective to be noted here. Elsabbagh and colleagues [4] focused their analyses on the P1, N290 and P400 components of the ERP signal, components that are modulated in a number of face perception tasks, including tests of sensitivity to the direction of eye gaze in infants as young as four months [6] . Critically, experiments from a number of laboratories around the world have identified these ERP components in infants as precursors of the well-established face-sensitive N170 component in adults [7] . Just over sixteen years ago, in the Yale Neuropsychology Laboratory, Gregory McCarthy, Shlomo Bentin, and their colleagues first described the 'N170': while recording from scalp electrodes in typically developing adult volunteers, they discovered that human faces and face parts (especially the eyes) reliably evoked a negative ERP at 172 ms (range 130-200 ms) that they labeled the N170. This response was absent from the ERPs elicited by many other animate and inanimate non-face objects, and was maximal over occipitotemporal electrode sites. This work, coupled with numerous behavioral findings concerning face-processing deficits in ASD, led researchers (including an author of this dispatch) to study the N170 in children, adolescents, and adults with ASD [8] . This set of events, from the basic science discovery of a neural signature for face processing in the human brain to its translation into a potential biomarker for the emergence of ASD represents the very finest in the emerging field of translational developmental social neuroscience.
